Wait Strategy May Be Riskier for Certain Prostate Cancers

February 23, 2015 10:00 PM

15 0

MONDAY, Feb. 23, 2015 (HealthDay News) -- Choosing active surveillance over treatment for prostate cancer may decrease the odds of survival in men with intermediate-risk cancer, a new study says.

The risk of death over 15 years for men with intermediate-risk prostate cancers who chose close monitoring of their disease was nearly four times higher compared to men with low-risk disease, according to the study.

Read more

To category page